37554-70-4Relevant articles and documents
Overcoming Time-Dependent Inhibition (TDI) of Cytochrome P450 3A4 (CYP3A4) Resulting from Bioactivation of a Fluoropyrimidine Moiety
Mandal, Mihirbaran,Mitra, Kaushik,Grotz, Diane,Lin, Xinjie,Palamanda, Jairam,Kumari, Pramila,Buevich, Alexei,Caldwell, John P.,Chen, Xia,Cox, Kathleen,Favreau, Leonard,Hyde, Lynn,Kennedy, Matthew E.,Kuvelkar, Reshma,Liu, Xiaoxiang,Mazzola, Robert D.,Parker, Eric,Rindgen, Diane,Sherer, Edward,Wang, Hongwu,Zhu, Zhaoning,Stamford, Andrew W.,Cumming, Jared N.
supporting information, p. 10700 - 10708 (2018/11/27)
Herein we describe structure-activity relationship (SAR) and metabolite identification (Met-ID) studies that provided insight into the origin of time-dependent inhibition (TDI) of cytochrome P450 3A4 (CYP3A4) by compound 1. Collectively, these efforts revealed that bioactivation of the fluoropyrimidine moiety of 1 led to reactive metabolite formation via oxidative defluorination and was responsible for the observed TDI. We discovered that substitution at both the 4- and 6-positions of the 5-fluoropyrimidine of 1 was necessary to ameliorate this TDI as exemplified by compound 19.
Facile and regioselective synthesis of novel 2,4-disubstituted-5- fluoropyrimidines as potential kinase inhibitors
Wada, Hiroki,Cheng, Lili,Jiang, Ji,Jiang, Zhigan,Xie, Jun,Hu, Tao,Sanganee, Hitesh,Luker, Tim
experimental part, p. 1720 - 1724 (2012/05/04)
2,4-Disubstituted-5-fluoropyrimidine is a biologically active molecular core seen in various anticancer agents such as 5-fluorouracil (5-FU). As part of a programme aimed at discovering kinase inhibitors, routes to two series of novel compounds (5-fluorop
IMIDAZOPYRIDINE DERIVATIVES AS JAK INHIBITORS
-
Page/Page column 112, (2011/07/09)
New imidazopyridine derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Janus Kinases (JAK).